187 related articles for article (PubMed ID: 33684151)
1. SNPs in genes encoding for IL-10, TNF-α, and NFκB p105/p50 are associated with clinical prognostic factors for patients with Hodgkin lymphoma.
Gaiolla RD; Moraes MPT; de Oliveira DE
PLoS One; 2021; 16(3):e0248259. PubMed ID: 33684151
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma.
Hohaus S; Giachelia M; Di Febo A; Martini M; Massini G; Vannata B; D'Alo' F; Guidi F; Greco M; Pierconti F; Larocca LM; Voso MT; Leone G
Ann Oncol; 2007 Aug; 18(8):1376-81. PubMed ID: 17496310
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.
Giachelia M; Voso MT; Tisi MC; Martini M; Bozzoli V; Massini G; D'Aló F; Larocca LM; Leone G; Hohaus S
Leuk Lymphoma; 2012 Mar; 53(3):411-6. PubMed ID: 21902578
[TBL] [Abstract][Full Text] [Related]
4. Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival.
Nielsen KR; Rodrigo-Domingo M; Steffensen R; Baech J; Bergkvist KS; Oosterhof L; Schmitz A; Bødker JS; Johansen P; Vogel U; Vangsted A; Dybkær K; Bøgsted M; Johnsen HE
Leuk Lymphoma; 2017 Nov; 58(11):2695-2704. PubMed ID: 28393658
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.
Ghesquières H; Maurer MJ; Casasnovas O; Ansell SM; Larrabee BR; Lech-Maranda E; Novak AJ; Borrel AL; Slager SL; Brice P; Allmer C; Brion A; Ziesmer SC; Morschhauser F; Habermann TM; Gaillard I; Link BK; Stamatoullas A; Fermé C; Dogan A; Macon WR; Audouin J; Cerhan JR; Salles G
Cytokine; 2013 Nov; 64(2):523-31. PubMed ID: 24008079
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of tumor necrosis factor promoter region and susceptibility to develop Hodgkin lymphoma in a Mexican population.
Torres-Espíndola LM; Velázquez-Cruz R; Falfán-Valencia R; Chavez-Pacheco JL; Salcedo-Vargas M; de Jesús Nambo-Lucio M; Salinas-Lara C; Alemón-Medina R; Granados-Montiel J; Reyes-Servín MA; Granados J; de Jesús Castillejos-López M
Leuk Lymphoma; 2014 Jun; 55(6):1295-9. PubMed ID: 24033107
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.
da Silva GN; Bacchi MM; Rainho CA; de Oliveira DE
Arch Pathol Lab Med; 2007 Nov; 131(11):1691-6. PubMed ID: 17979488
[TBL] [Abstract][Full Text] [Related]
8. Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia.
Bănescu C; Tripon F; Trifa AP; Crauciuc AG; Moldovan VG; Bogliş A; Benedek I; Dima D; Cândea M; Duicu C; Iancu M
Cancer Med; 2019 Sep; 8(12):5492-5506. PubMed ID: 31373163
[TBL] [Abstract][Full Text] [Related]
9. Association of Single Nucleotide Polymorphisms of the
Wei Q; Chen X; Chen H
Genet Test Mol Biomarkers; 2020 Jul; 24(7):390-398. PubMed ID: 32513030
[No Abstract] [Full Text] [Related]
10. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
Balakrishnan VS; Guo D; Rao M; Jaber BL; Tighiouart H; Freeman RL; Huang C; King AJ; Pereira BJ;
Kidney Int; 2004 Apr; 65(4):1449-60. PubMed ID: 15086488
[TBL] [Abstract][Full Text] [Related]
11. Significant association of TNF-α, but not other pro-inflammatory cytokines, single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population.
Abdollahzade S; Hanaei S; Sadr M; Mirbolouk MH; Fattahi E; Rezaei N; Khoshnevisan A
Clin Neurol Neurosurg; 2018 Oct; 173():77-83. PubMed ID: 30092407
[TBL] [Abstract][Full Text] [Related]
12. Gene polymorphisms of interleukin-10 and tumor necrosis factor-α are associated with contrast-induced nephropathy.
Chang CF; Lu TM; Yang WC; Lin SJ; Lin CC; Chung MY
Am J Nephrol; 2013; 37(2):110-7. PubMed ID: 23363891
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.
Du GH; Wang JK; Richards JR; Wang JJ
Int Immunopharmacol; 2019 Jan; 66():154-161. PubMed ID: 30453149
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.
Wang Z; Liu QL; Sun W; Yang CJ; Tang L; Zhang X; Zhong XM
Croat Med J; 2014 Dec; 55(6):638-46. PubMed ID: 25559835
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of Pro- and Anti-Inflammatory Cytokines in Patients With cHL Persists Despite Treatment Compared With Control Subjects.
da Silva PB; Perini GF; Pereira Lde A; Sacconato EM; Penna AM; Garibaldi J; Cavalcante E; Baiocchi OC
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S151-7. PubMed ID: 26297269
[TBL] [Abstract][Full Text] [Related]
16. [Association of the tumor necrosis factor-alpha -1031T/C and its combination with interleukin-6 -634C/G gene polymorphisms with susceptibility to endometriosis].
Mao T; Zong LL; Wang YF; Zeng J; Fu YG; Zhao X; Rao XQ; Huang YX; Xu ZM; Zhu XN
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):328-32. PubMed ID: 22883518
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.
Schoof N; Franklin J; Fürst R; Zander T; von Bonin F; Peyrade F; Trümper L; Diehl V; Engert A; Kube D; Re D
Oncologist; 2013; 18(1):80-9. PubMed ID: 23299779
[TBL] [Abstract][Full Text] [Related]
18. Inherited variant in NFκB-1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding.
Hamadou I; Garritano S; Romanel A; Naimi D; Hammada T; Demichelis F
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1240. PubMed ID: 32671985
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
20. Influence of
Braga M; Lara-Armi FF; Neves JSF; Rocha-Loures MA; Terron-Monich MS; Bahls-Pinto LD; de Lima Neto QA; Zacarias JMV; Sell AM; Visentainer JEL
Front Immunol; 2021; 12():653611. PubMed ID: 34290697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
